Trial intelligence / Profile preview

Subcutaneous Lyophilized Alpha-Erythropoietin to Maintain Hemoglobin in Hemodialysis Patients

TCTR20161214001Phase 4Completed

Sponsor
Phramongkutklao Hospital and College of Medicine
Start
Jan 2015
Countries
1
01

Overview

Phase 4, single-arm trial in anaemia, sponsored by Phramongkutklao Hospital and College of Medicine. Primary endpoints: Maintenance of hemoglobin concentration and Safety of alpha-erythropoietin. Started Jan 2015; status: completed.

02

Conditions

anaemia

Beyond the preview

Go deeper on TCTR20161214001.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20161214001.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call